half life of glp 1 agonists Recent updates on GLP-1 agonists: Current advancements & challenges This review summarizes how GLP-1

doi: 10.1371/journal.pone.0058784 [DOI] [PMC free article] [PubMed] [Google Scholar] 169

Patients were also less likely to die or require hospitalization when taking GLP-1 drugs, the study found

Facebook Email or phone Password Forgot account

In that study, the glucose-sensing transcription factor carbohydrate response element binding protein (ChREBP) has been shown to initiate a regulatory program driving an early transcriptional activation of metabolic genes, which is followed by a second wave of transcriptional regulation wherein cell-cycle genes are activated and -cell identity genes are repressed

10.1038/sj.cdd.4401373 134 Ozdemir KutbayN.Biray AvciC.Sarer YurekliB.Caliskan KurtC.ShademanB.GunduzC.et al (2020)

Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research